Edition:
United Kingdom

VBI Vaccines Inc (VBIV.OQ)

VBIV.OQ on NASDAQ Stock Exchange Capital Market

2.73USD
18 Jul 2018
Change (% chg)

$-0.15 (-5.21%)
Prev Close
$2.88
Open
$2.80
Day's High
$2.81
Day's Low
$2.69
Volume
65,941
Avg. Vol
88,576
52-wk High
$5.10
52-wk Low
$2.59

Select another date:

Thu, May 10 2018

BRIEF-VBI Vaccines Announces Positive Final Phase 1 Study Results Of Preventative CMV Vaccine

* VBI VACCINES ANNOUNCES POSITIVE FINAL PHASE 1 STUDY RESULTS OF PREVENTATIVE CMV VACCINE

BRIEF- Vaccines Posts Q1 Loss Per Share $0.19

* VBI VACCINES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study

* VBI VACCINES ANNOUNCES POSITIVE DSMB REVIEW IN PHASE 1/2A STUDY OF VBI-1901 IN RECURRENT GLIOBLASTOMA (GBM) PATIENTS

BRIEF-Vbi Vaccines Announces Voluntary Delisting From The Toronto Stock Exchange

* VBI VACCINES ANNOUNCES VOLUNTARY DELISTING FROM THE TORONTO STOCK EXCHANGE

BRIEF-VBI Vaccines Announces Changes To Its Board Of Directors

* VBI VACCINES INC - TOMER KARIV, CHAIRMAN AND CEO OF PONTIFAX GROUP, TO REPLACE RAN NUSSBAUM ON VBI'S BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Select another date: